The essential nutrients required in the diet are vitamins, carbohydrates, fats, proteins, and minerals. Clinical nutrition helps to treat and control several diseases such as cardiovascular disease, diabetes, GI diseases, cancer and kidney diseases through the supply of essential nutrients for optimal functioning of various organs of the body. Clinical nutrition is available in the form of liquids, powders, tablets, injections, or foods such as yogurt and Probiotics.
One of the main drivers of this market is a marked increase in the incidence and prevalence of various diseases and illnesses globally. Further, the increasing aging population worldwide is contributing to the growth of the market. However, one of the major challenges in this market is the unfavorable reimbursement regulations imposed by the government in various countries. Price-conscious consumers are not able to afford these products because of the lack of standardization in reimbursement norms.
The high demand for clinical nutrition products in Australia, China, and India are driving the growth of the market in the APAC region. In 2009, total market value for clinical nutrition in Japan was USD 1.2billion.
The Asia-Pacific clinical nutrition market is segmented by type of applications(Infant, child, adult, sports nutrition, and therapeutic nutrition), ingredients( vitamins and amino acids, minerals and glucose), type of services(diarrhea, cancer, diabetes, renal diseases, protein malabsorption etc.), route of administration(oral, tube feeding and parenteral) and country (India, China and Japan).
The key players in the market are focused on the expansion of the business by launching new products and extending the product line. Mergers and acquisitions of small and medium-sized manufacturers to enter in overseas market is another strategy adopted by multinational players. Analyzing the market share of major companies, 3 producers of Nutrients, Abbott Japan, Otsuka and Ajinomoto contributed 41%, 38%, and 21% respectively. There are multiple producers, local and multinational who will be entering the market in coming years. The majority of the growth is seen in fluids, accounting for 8% of the market.
This Report Offers:
Market definition for the Asia-Pacific clinical nutrition market along with identification of key drivers and restraints for the market.
Market analysis for the Asia-Pacific clinical nutrition market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.
Wide-ranging information provided about the leading market players and the major strategies adopted by them.
1.1 Market Definition
1.2 Market Size Estimation
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.1 Market Introduction
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market opportunities
3.2.4 Porter's Five Force Analysis
220.127.116.11 Threat of a new entrant
18.104.22.168 Internal Rivalry
22.214.171.124 Buyer Bargaining Power
126.96.36.199 Supplier Bargaining Power
188.8.131.52 Threat of substitutes
4. Global Medical Nutrition Market Segmentation
4.1 By Applications
4.1.4 Sports Nutrition
4.1.5 Therapeutic Nutrition
4.2 By Ingredients
4.2.1 Vitamins & Amino acids
4.3 By Services
4.3.1 Protein Maldigestion
4.3.3 Food allergies
4.3.7 Short-bowel syndrome
4.3.8 GI-tract impairment
4.3.9 Acute lung injury (ALI)
4.3.10 Acute Respiratory Distress (ARDS)
4.4 By Route of Administration
4.5 By Geography
5. Competitive Landscape
5.2 Market Share Analysis
5.3 Most Active Companies by Market Strategies
5.4 Mergers & Acquisitions
5.5 Agreements, Partnerships, Collaborations & Joint Ventures
6. Company Profiles
6.1 Abbott Healthcare
6.2 Nestle Health Sciences
6.3 Danone medical Nutrition
6.4 Fresenius Kabi
6.5 Baxter Healthcare and Peptide
6.6 B. Braun Melsungen AG